Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.122
-0.008 (-0.73%)
After-hours: Apr 28, 2026, 7:47 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $52.68 million as of April 28, 2026. Its market cap has decreased by -31.37% in one year.
Market Cap
52.68M
Enterprise Value
45.13M
1-Year Change
-31.37%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $52.68M, a decrease of -26.59%. That is a compound annual growth rate of -3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 51.75M | -41.83% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 54.80M |
| Cingulate | 54.42M |
| MiNK Therapeutics | 54.03M |
| Kezar Life Sciences | 54.00M |
| Metagenomi Therapeutics | 53.99M |
| Radiopharm Theranostics | 50.84M |
| Telomir Pharmaceuticals | 49.85M |
| Hyperion DeFi | 48.53M |